Nuyten Dimitry SA 4
4 · ADURO BIOTECH, INC. · Filed May 15, 2019
Insider Transaction Report
Form 4
Nuyten Dimitry SA
Chief Medical Officer
Transactions
- Award
Initial Option Grant
2019-05-13+400,000→ 400,000 totalExercise: $2.98Exp: 2029-05-12→ Common Stock (400,000 underlying)
Footnotes (1)
- [F1]The shares subject to the initial option grant vest 1/4 after the first year, the remaining shares will vest monthly over 36 months.